| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.45T | 48.04T | 45.10T | 37.15T | 31.38T | 27.21T |
| Gross Profit | 8.89T | 9.58T | 9.37T | 6.31T | 5.97T | 4.83T |
| EBITDA | 7.27T | 8.27T | 8.39T | 5.19T | 5.30T | 4.27T |
| Net Income | 3.70T | 4.77T | 4.94T | 2.45T | 2.85T | 2.25T |
Balance Sheet | ||||||
| Total Assets | 10.00T> | 93.60T | 90.11T | 74.30T | 67.69T | 62.27T |
| Cash, Cash Equivalents and Short-Term Investments | 7.92T | 15.92T | 14.11T | 9.23T | 8.62T | 9.32T |
| Total Debt | 42.13T | 38.79T | 36.56T | 29.38T | 26.50T | 25.66T |
| Total Liabilities | 62.35T | 56.72T | 54.87T | 45.04T | 40.53T | 37.98T |
| Stockholders Equity | 38.97T | 35.92T | 34.22T | 28.34T | 26.25T | 23.40T |
Cash Flow | ||||||
| Free Cash Flow | 334.81B | -1.21T | -842.02B | -750.76B | -107.63B | -1.04T |
| Operating Cash Flow | 4.64T | 3.70T | 4.21T | 2.96T | 3.72T | 2.73T |
| Investing Cash Flow | -5.02T | -4.19T | -5.00T | -1.60T | -577.50B | -4.68T |
| Financing Cash Flow | -5.76B | 197.24B | 2.50T | -56.18B | -2.47T | 2.74T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥3.69T | 9.91 | 13.26% | 1.85% | 2.99% | 9.99% | |
68 Neutral | ¥42.63T | 8.70 | 12.89% | 2.78% | 6.44% | 11.88% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥5.06T | 9.73 | 4.09% | 4.41% | -0.43% | -26.68% | |
58 Neutral | $1.83T | -82.83 | 9.73% | 3.61% | 1.04% | -31.52% | |
55 Neutral | ¥668.29B | 6.29 | 1.72% | 4.52% | -0.83% | -75.20% | |
47 Neutral | ¥1.19T | -12.05 | -16.69% | ― | -3.01% | -755.71% |